Latest Press Releases

Cority Welcomes New CFO and CMO

TORONTO, March 13, 2025 (GLOBE NEWSWIRE) -- Cority, the global leader in enterprise Environmental, Health, and Safety (EHS) and Sustainability software, announced the appointment of two key executives, Sukaran Mehta as Chief Financial Officer ...

The Role of CRISPR Libraries in Advancing Cancer Research: From Target Identification to Personalized Therapy

CRISPR-Cas9 technology has revolutionized genetic research, providing an efficient method for gene editing. CRISPR libraries , collections of guide RNAs (gRNAs) designed for large-scale genetic screens, have emerged as powerful tools in cancer ...

Philips Highest Ranked Medical Technology Company Among Clarivate Top 100 Global Innovators

March 12, 2025 - Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has been recognized by Clarivate as the top-ranked medical technology company in the Top 100 Global ...

The Benefits of Health Insurance for Senior Citizens

Ageing is inevitable, but no one should face financial problems during medical emergencies. Senior citizens, especially, are at a higher risk of facing unique health challenges, from chronic illnesses to unexpected hospitalisations. With the ...

Embracing change: AI's Influence on Tech Careers

Change is part of life. The tech world knows this well. In the last few years, AI has changed how we work. It has changed what jobs look like. It has changed what skills we need. For tech workers in India, this shift brings both fear and hope. ...

How Much Term Insurance Coverage Do You Really Need? Here Is the Right Formula

How much life cover is enough? Should it be ₹50 lakh? ₹1 crore? Or something more like ₹5 crore? Most of us struggle to figure out the adequate life cover after deciding to buy term insurance plan and may end up under insured. ...

Make Sleep Health a Priority on World Sleep Day This Friday, March 14

PR Newswire ROCHESTER, Minn., March 13, 2025 World Sleep Society is calling for health advocates worldwide to promote the power of healthy sleep on World Sleep Day this Friday, March 14. Over 600 volunteer organizers have already committed ...

Blue Earth Therapeutics Reports Key Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial

PR Newswire OXFORD, United Kingdom, March 13, 2025 - Data from the Phase 1 trial in metastatic prostate cancer suggest potential for highly optimized pharmacokinetics - Improved tumour: normal organ ratios may allow the delivery of ...

Valcare Medical Receives FDA Approval to Initiate Early Feasibility Study for its Novel AMEND™ Trans-Septal System

PR Newswire HERZLIYA, Israel and WILMINGTON, Del., March 13, 2025 HERZLIYA, Israel and WILMINGTON, Del., March 13, 2025 /PRNewswire/ -- Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the ...

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

PR Newswire LONDON, March 13, 2025 LONDON, March 13, 2025 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis ...

Feed The Recovering Brain Summit 2025: Powerful Nutritional Strategies for Effective Treatment and Sustained Recovery sponsored by Eating Protein Saves Lives, Inc.

PR Newswire COLUMBUS, Ohio, March 13, 2025 COLUMBUS, Ohio, March 13, 2025 /PRNewswire/ -- The Feed The Recovering Brain Summit 2025 is a three-day conference happening April 30 – May 2, 2025, at Embassy Suites by Hilton Columbus Dublin in ...

Third Arc Bio Announces First Patient Dosed in Phase 1 Clinical Trial of Lead T Cell Engager ARC101 to Treat CLDN6 Positive Cancers

PR Newswire SPRING HOUSE, Pa., March 13, 2025 -- ARC101 is the company's first bispecific antibody targeting Claudin 6 (CLDN6), optimized for best-in-class T cell engagement -- First-in-human study will evaluate the safety, tolerability, ...

SpliceBio Announces First Patient Dosed in Phase 1/2 ASTRA Study of SB-007, a Dual-AAV Gene Therapy for Stargardt Disease

PR Newswire BARCELONA, Spain, March 13, 2025 BARCELONA, Spain, March 13, 2025 /PRNewswire/ -- SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, today ...

Andrew and Shahar Engbring Launch Reflection Family Interventions, Redefining Family-Centered Support for Addiction and Mental Health Crises

PR Newswire PHOENIX, March 13, 2025 Industry veterans Andrew and Shahar Engbring are revolutionizing the intervention process with Reflection Family Interventions, offering families expert guidance before, during, and after an intervention. ...

IFPA Forum Americas 2025: "Towards More Equitable, Person-Centered Care for All People Living with Psoriatic Disease in the Americas"

PR Newswire STOCKHOLM, March 13, 2025 On April 4, 2025, IFPA will host the IFPA Forum 2025 for the Americas in Bogotá, Colombia. This marks the third regional forum of its kind, following successful gatherings in Europe (2022) and Asia ...

New Breakthrough 'Faith Over Fear' Program Transforms Anxiety into Confidence for Professionals in Just 10 Weeks

PR Newswire JACKSONVILLE, Fla., March 13, 2025 90% of Participants Report Overcoming Fear, Reducing Panic Attacks, and Improving Sleep Within Two Months JACKSONVILLE, Fla., March 13, 2025 /PRNewswire/ -- Leadership coach Eric Gilbert, ...

BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors

PR Newswire SHANGHAI, March 13, 2025 SHANGHAI, March 13, 2025 /PRNewswire/ -- BioCity Biopharmaceutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that it has entered into a clinical trial collaboration agreement ...

The Role of CRISPR Libraries in Advancing Cancer Research: From Target Identification to Personalized Therapy

CRISPR-Cas9 technology has revolutionized genetic research, providing an efficient method for gene editing. CRISPR libraries , collections of guide RNAs (gRNAs) designed for large-scale genetic screens, have emerged as powerful tools in cancer ...

GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T-Cell Lymphoma CD5 CAR-NK Therapy

PR Newswire YONGIN, South Korea, March 12, 2025 YONGIN, South Korea, March 12, 2025 /PRNewswire/ -- GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for ...

STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States

PR Newswire JERSEY CITY, N.J., March 12, 2025 JERSEY CITY, N.J., March 12, 2025 /PRNewswire/ -- Celltrion today announced the U.S. launch of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), following approval by the U.S. ...

ROZLYTREK's Market Growth Reflects Transforming Treatment for NTRK and ROS1-Positive Cancers | DelveInsight

PR Newswire LAS VEGAS, March 12, 2025 As biomarker testing and the demand for tumor-agnostic therapies rise, ROZLYTREK can potentially target a specialized yet valuable market segment. While competition from other TRK inhibitors, such as ...

New Consortium to Transform Pediatric Tonsillectomy and Adenoidectomy Care

PR Newswire SEATTLE, March 12, 2025 Consortium for Improvement of Tonsillectomies and Adenoidectomies Launches with Seattle Children's, Nemours Children's, and Children's Minnesota as Inaugural Participants SEATTLE, March 12, 2025 ...

Console & Associates P.C. Investigating Depo-Provera Injuries: Meningioma Brain Tumor Risks for Women Using Injectable Contraceptives

PR Newswire MARLTON, N.J., March 12, 2025 MARLTON, N.J., March 12, 2025 /PRNewswire/ -- A growing number of women who received Depo-Provera injections are coming forward with serious health concerns following new research linking the ...

RedHill Biopharma Advances its Groundbreaking Late-Stage Crohn's Disease Program Building on Statistically Significant Positive RHB-104 Phase 3 Results

PR Newswire RALEIGH, N.C. and TEL-AVIV, Israel, March 12, 2025 The planned innovative Phase 2 study of RHB-2041 will be the first ever clinical study in Crohn's Disease (CD) patients who are all MAP-positive, and will correlate mucosal ...

New Research from Hopelab and Born This Way Foundation Reveals Online Spaces Provide a Lifeline to LGBTQ+ Young People

PR Newswire SAN FRANCISCO, March 12, 2025 SAN FRANCISCO, March 12, 2025 /PRNewswire/ -- New research from Hopelab and Born This Way Foundation examines how LGBTQ+ young people connect to online friendships and communities to explore their ...

Vivace Therapeutics Raises $35 Million in Series D Financing to Support Clinical Development of First-in-Class Cancer Drug Targeting the Hippo Pathway

PR Newswire SAN MATEO, Calif., March 12, 2025 Financing Led by RA Capital Management with Participation from Other Existing Investors Canaan Partners and Cenova Capital VT3989 is the Only TEAD Autopalmitoylation Inhibitor for which ...

Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generation Obesity Therapies

PR Newswire CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 12, 2025 - Élancé Therapeutics aims to improve current obesity treatment, specifically to increase overall body weight loss and fat mass loss, but preserve and even ...

Children's Respite Homes of America Aims to Address the Severe Lack of Children's Respite and Palliative Care Homes in the U.S.

PR Newswire SCOTTSDALE, Ariz., March 11, 2025 Only a handful of respite homes exist in America, yet nearly 1 million medically fragile children could benefit from this critical care. Now, Children's Respite Homes of America aims to address ...

Ascletis Announces Positive Topline Results of Phase Ib Studies of ASC47 Monotherapy in Australia and U.S. FDA Clearance of IND Application for ASC47 in Combination with Semaglutide

PR Newswire HONG KONG, March 11, 2025 HONG KONG, March 11, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces encouraging pharmacokinetic and weight loss data from its ASC47 Phase Ib single subcutaneous injection ...

New Study Reveals Significant Improvements in Recovery Assessment Scores of 20,000 Patients at Discovery Behavioral Health

PR Newswire LOS ANGELES, March 11, 2025 LOS ANGELES, March 11, 2025 /PRNewswire/ -- Discovery Behavioral Health, Inc. (DBH) announced a newly published study, Changes in Recovery Assessment Scale Scores During a Treatment Episode Among ...

All-Female Surgical Team at Pittsburgh's Allegheny General Hospital Performs Cardiac Surgery in Honor of International Women's Day

PR Newswire PITTSBURGH, March 11, 2025 Students from local high school provided with bird's eye view of operating room as part of program designed to inspire careers in medicine PITTSBURGH, March 11, 2025 /PRNewswire-PRWeb/ -- In ...

American Parkinson Disease Association to Educate and Empower During Parkinson's Disease Awareness Month

PR Newswire NEW YORK, March 11, 2025 APDA helps the Parkinson's community live life to the fullest in April and year-round. With a diagnosis every six minutes, public awareness and support are crucial. NEW YORK, March 11, 2025 ...

HealthTree Foundation Launches New Mobile App to Empower Blood Cancer Patients

PR Newswire SALT LAKE CITY, March 10, 2025 HealthTree App Offers Patient Support, Education, and Research Participation in One Seamless Platform SALT LAKE CITY, March 10, 2025 /PRNewswire/ -- HealthTree Foundation, a global nonprofit ...

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy

PR Newswire PALO ALTO, Calif., March 10, 2025 PALO ALTO, Calif., March 10, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today announced that it has completed enrollment in its GLOW2 Phase 3 clinical trial of tarcocimab tedromer ...

Protecting Women's Health: Visionary's Precision Cervical Cancer Screening Public Welfare Activity Brings Health Blessings to Women

PR Newswire TORONTO, March 10, 2025 TORONTO, March 10, 2025 /PRNewswire/ -- On March 8, 2025, the public welfare activity of "Celebrating International Women's Day and Caring for Women's Health" and the "Global Press Conference of E7 Protein ...

Healthy environment for youth stressed

PR Newswire BEIJING, March 10, 2025 BEIJING, March 10, 2025 /PRNewswire/ -- The following article was published today by China Daily. Chinese courts will further strengthen measures aimed at preventing children from committing crimes, ...

Latest Press Releases

Premium Press Releases »

Press Releases »

Medindia Newsletters

Latest Press Releases

Follow Us On :